An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-45
SponsorZenchi, Inc.
About this trial
This is a 24-week, single-arm, open-label, virtual study evaluating the effects of Elix Cycle Balance and Elix Daily Harmony on uterine fibroid-related symptoms and quality of life in 42 participants. Participants will self-administer the investigational herbal supplements daily and complete validated questionnaires at scheduled timepoints to assess symptom severity and quality of life.
Eligibility criteria
Qualifiers
Be female.
Be aged 20-45.
BMI 18.5 - 24.9 kg/m2
Self-reported prior diagnosis of uterine fibroids.
Disqualifiers
Does not experience a regular menstrual cycle (21-35 days).
Does not experience menstrual cramping.
Follows an extreme diet intervention such as dry fasts, water fasts, or ketogenic diets.
Anyone who has experienced significant weight loss in the past three months prior to study participation.
Trial design
Treatments tested in this trial
- Elix Daily Harmony
Treatment groups
42 Participants
are divided into 1 treatment groupSponsors and collaborators
Zenchi, Inc.
Lead sponsor
Citruslabs
Collaborator
Source ClinicalTrials.gov